Page last updated: 2024-10-30

mechlorethamine and Lambert-Eaton Myasthenic Syndrome

mechlorethamine has been researched along with Lambert-Eaton Myasthenic Syndrome in 1 studies

nitrogen mustard : Compounds having two beta-haloalkyl groups bound to a nitrogen atom, as in (X-CH2-CH2)2NR.

Lambert-Eaton Myasthenic Syndrome: An autoimmune disease characterized by weakness and fatigability of proximal muscles, particularly of the pelvic girdle, lower extremities, trunk, and shoulder girdle. There is relative sparing of extraocular and bulbar muscles. CARCINOMA, SMALL CELL of the lung is a frequently associated condition, although other malignancies and autoimmune diseases may be associated. Muscular weakness results from impaired impulse transmission at the NEUROMUSCULAR JUNCTION. Presynaptic calcium channel dysfunction leads to a reduced amount of acetylcholine being released in response to stimulation of the nerve. (From Adams et al., Principles of Neurology, 6th ed, pp 1471)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Homenda, W1
Hellmann, A1

Other Studies

1 other study available for mechlorethamine and Lambert-Eaton Myasthenic Syndrome

ArticleYear
[Hodgkin's disease with systemic vasculitis and Lambert-Eaton myasthenic syndrome--case report].
    Wiadomosci lekarskie (Warsaw, Poland : 1960), 2000, Volume: 53, Issue:9-10

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Doxorubicin; Hodgkin Disease; Humans; Lam

2000
chemdatabank.com